3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
44
Polycystic Ovary Syndrome
10
Breast Diseases
4
Advanced Breast Cancer
4
Infertility
3
Recurrence
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Infertility, Female
2
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1
Vitamin D Deficiency
1
Uterine Cervical Neoplasms
1
Solid Tumor
1
Pathologic Processes
1
Obesity
1
Myofibroma
1
Locally Advanced Breast Cancer
1
Hypoxia
1
Hydatidiform Mole
1
HER2+ Breast Cancer
1
Gestational Trophoblastic Disease
1
Endometrioid Endometrial Cancer
1
Endometrial Neoplasms
1
ER Positive, HER2 Negative Breast Cancer
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Organoids
1
Anovulation
1
Interventions
Cisplatin
44
Paclitaxel
21
Radiotherapy
20
Brachytherapy
19
Carboplatin
18
Bevacizumab
7
Drug Therapy
6
camrelizumab
5
toripalimab
4
nimotuzumab
4
Radiation
4
Neoadjuvant Therapy
4
Gemcitabine
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
apatinib
3
Vaccines
3
TP protocol
3
Surgical Procedures, Operative
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
nedaplatin
2
fludarabine
2
endostar protein
2
anlotinib
2
Topotecan
2
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Mindfulness
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Cervical Neoplasms
×
Letrozole
×
Clear all
NCT02482740
2015-06-26
TGOG1005
Buddhist Tzu Chi General Hospital
Phase 2
Unknown
44 enrolled